Celtaxsys' Lead Pipeline Immuno-Modulator for CF Granted Orphan Drug … – Cystic Fibrosis News Today
Celtaxsys' Lead Pipeline Immuno-Modulator for CF Granted Orphan Drug …Cystic Fibrosis News TodayCeltaxsys, Inc., a privately-owned, clinical stage drug discovery and development company focused on addressing serious inflammatory diseases, has just announced the U.S. Food and Drug Administration has granted the company's experimental therapy …
[monetize id=”1″]
[monetize id=”2″]
Natasha Nassar – My Story
